Yumanity Therapeutics Financial Health
How is Yumanity Therapeutics's financial position?
Financial Health Score3/6
Financial Health Score 3/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: YMTX's short term assets ($14.5M) exceed its short term liabilities ($7.5M).
Long Term Liabilities: YMTX has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: YMTX has more cash than its total debt.
Reducing Debt: Insufficient data to determine if YMTX's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: YMTX has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: YMTX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 20.4% each year